Table 2.
Main treatment effect by primary drug, type of CBT treatment, and type of comparison condition
Variable | Alcohol | Marijuana | C/S/O | Polydrug | CBT | CBT + psychosoc. | CBT + pharm. | Vs active treatment | Vs passive treatment | Vs no treatment | Vs no adjunct |
Fixed effects | 0.067a | 0.513b§ | 0.126c* | 0.116 | 0.165d§ | 0.329e* | 0.208f§ | 0.129g§ | 0.116§ | 0.848§ | 0.089h |
95% CI | −0.002, 0.136 | 0.375, 0.651 | 0.011, 0.242 | −0.007, 0.239 | 0.085, 0.245 | 0.238, 0.421 | 0.070, 0.346 | 0.041, 0.217 | 0.052, 0.180 | 0.692, 1.010 | −0.066, 0.244 |
Range | −0.670, 1.209 | 0.225, 0.824, | −0.845, 0.626 | −0.442, 0.642 | −0.644, 0.626 | −0.239, 1.210 | −0.451, 0.867 | −0.644, 0.626 | −0.451, 0.867 | 0.288, 1.210 | −0.845, 0.523 |
N | 23 | 6 | 13 | 11 | 21 | 19 | 13 | 17 | 32 | 6 | 7 |
Q (df) | 34.20 (22)* | 10.53 (5) | 40.39 (12)§ | 10.96 (10) | 37.80 (20)* | 64.23 (18)§ | 18.53 (12) | 20.09 (16) | 34.10 (31) | 18.66 (5)§ | 35.21 (6)§ |
I2 | 35.67* | 52.53 | 70.29 | 8.72 | 47.09 | 71.97 | 35.25 | 20.38 | 31.26 | 73.21 | 82.96 |
Random effects | 0.088 | 0.470§ | 0.133 | 0.113 | 0.172* | 0.305§ | 0.199* | 0.133* | 0.152§ | 0.796§ | −0.054 |
95% CI | −0.018, 0.194 | 0.259, 0.681 | −0.084, 0.350 | −0.020, 0.246 | 0.053, 0.292 | 0.116, 0.493 | 0.021, 0.376 | 0.029, 0.238 | 0.062, 0.242 | 0.454, 1.140 | −0.455, 0.348 |
Notes: C/S/O = cocaine/stimulant/opiate; CBT = cognitive-behavioral treatment; psychosoc. = psychosocial; pharm. = pharmacological; CI = confidence interval.
The trimmed estimate with three outlying (Kelly et al., 2000; O'Malley et al., 1992; Sandahl et al., 2004) and two high weight (Anton et al., 2006; Project MATCH, 1997) trials removed was larger, significant, and homogeneous (g = 0.14, p < .05, Q > .05);
the estimate with one high-weight study (MTRP, 2004) removed was 0.38 (p < .005, Q > .05);
the trimmed estimate with two outlying trials (Carroll et al., 1991; Rawson et al., 2006) removed was slightly larger but remained heterogeneous (g = 0.19, p < .05, Q < .05);
the trimmed estimate with one outlying trial (Sandahl et al., 2004) removed was slightly higher (g = 0.18, p < .005, Q < .05) but remained heterogeneous;
the trimmed estimate with two outlying studies (Kelly et al., 2001; MTRP, 2004) removed was lower and homogeneous (g = 0.20, p < .005, Q > .05);
the trimmed estimate with one outlying study (Heinälä et al., 2001) removed was slightly lower (g = 0.19, p < .05, Q > .05); Anton et al. (2006) not included in analyses because it qualifies as both a psychosocial and pharmacological combined intervention;
positive effect comparisons include interpersonal psychotherapy (Carroll et al., 1991, 2004; Donovan and Ito, 1988), twelve-step facilitation (Brown et al., 2002; Maude-Griffin et al., 1998), motivational interviewing (Anton et al., 2005; Stephens et al., 2000), and contingency management (Budney et al., 2006);
the trimmed estimate with one outlying trial (Rawson et al., 2006) removed was larger, significant but remained heterogeneous (g = 0.22, p < .05, Q < .05).
p <.05,
p<.005.